Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-67.16	153.20	466.56
Graham Fair Price	150.62	1.32	0.53
PEG	-97.72	0.14	-6.06
Price/Book	-28.26	3.33	4.64
Price/Cash Flow	41.59	136.72	96.56
Prices/Earnings	-82.38	55.64	315.83
Price/Sales	-19.09	17.37	21.47
Price/FCF	41.59	136.72	96.56
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	19.05	0.44	0.37
Operating Margin	1334.38	0.08	< 0.005
ROA	327.19	0.01	< 0.005
ROE	< 0.005	0.01	307.27
ROIC	< 0.005	0.01	448.69
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.11	-0.01	-798.59
Dividends QOQ	-0.25	0.02	-91.60
EBIT QOQ	-0.77	11.91	1448.09
EPS QOQ	-0.52	4.03	673.21
FCF QOQ	0.92	-0.49	-47.10
Revenue QOQ	< 0.005	-0.10	-14610.56
Naive Interpretation	member

03 - Financial Growth · Balanced

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	127.61	144.95	13.59
Days Sales Outstanding (DSO)	52.61	60.69	15.35
Inventory Turnover	0.71	0.62	-11.96
Debt/Capitalization	0.23	0.21	-9.85
Quick Ratio	0.68	0.77	12.31
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	1.84	2.28	24.19
Cash	0.32	0.37	13.96
Capex	< 0.005	< 0.005	65.86
Free Cash Flow	0.09	0.06	-37.07
Revenue	0.40	0.44	10.12
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.19	1.28	7.81
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	11.83	4.40	-62.83
Naive Interpretation	Member

06 - Financial Health · Weak

Rating